Differential Factor-Level MADRS Response Associated With Seizure Duration in Electroconvulsive Therapy: Exploratory...

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Research

Background:

• Electroconvulsive therapy (ECT) is a key treatment for severe depression.
• Understanding ECT's mechanisms, like seizure duration's impact, is crucial for optimizing treatment.
• Interindividual response variability in ECT necessitates further investigation.

Purpose of the Study:

• To explore the influence of electroencephalogram (EEG)-measured seizure duration on depressive symptoms.
• To identify potential optimal seizure duration ranges for maximizing ECT efficacy.

Main Methods:

• Retrospective analysis of 53 participants with depression treated with ECT.
• Categorization of seizure duration into short (25-39s), medium (40-59s), and long (≥60s) groups.
• Statistical analysis (Kruskal-Wallis, regression) of MADRS score changes and symptom clusters.

Main Results:

• A medium seizure duration (40-59s) group showed the most significant improvement in overall MADRS scores.
• This medium duration group also demonstrated significant reductions in anxiety and vegetative symptom clusters.
• No statistically significant differences were found for affective, anhedonic, or hopelessness symptoms across seizure duration groups.

Conclusions:

• An optimal seizure duration window of 40-59 seconds appears most effective for reducing overall depressive symptom severity.
• Specific symptom clusters, like anxiety and vegetative symptoms, benefit most from this medium seizure duration.
• Further research is warranted to elucidate the intricate relationship between seizure dynamics and ECT outcomes.